Guardant Health, Inc. (GH) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-30 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Guardant Health, Inc. (GH) CIK: 0001576280 --- Reporting Owner --- Name: Krognes Steve E. CIK: 0001666236 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-30 | Code: M (Exercise of derivative) Shares: +155 | Price: $0.00 Shares Owned After: 14,580 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-06-30 | Code: M (Exercise of derivative) Shares: -155 | Price: $0.00 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] This represents a restricted stock unit award granted on August 9, 2022. 25% of the shares subject to such award vested on June 30, 2023 and the remaining 75% of the shares subject to such award vested during the three-year period thereafter. [F2] Not applicable for Restricted Stock Units. --- Footnotes (Complete Index) --- F1: This represents a restricted stock unit award granted on August 9, 2022. 25% of the shares subject to such award vested on June 30, 2023 and the remaining 75% of the shares subject to such award vested during the three-year period thereafter. F2: Not applicable for Restricted Stock Units. --- Signature --- /s/ /s/ John Saia, as attorney-in-fact for Steve Krognes (2026-07-02)